Jean-San Chia

Jean-San Chia

Auto-generated profile, based on publicly available information

Jean-San Chia

Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2012 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
CJChiau-Jing Jung
Chiau-Jing Jung
CYChiou-Yueh Yeh
Chiou-Yueh Yeh
CSChia-Tung Shun
Chia-Tung Shun
RHRon-Bin Hsu
Ron-Bin Hsu
HCHung-Wei Cheng
Hung-Wei Cheng
JCJean-San Chia
Jean-San Chia
Infective endocarditis is a typical biofilm-associated infectious disease frequently caused by commensal streptococci, but the contribution of host factors in biofilm formation is unclear. We found that platelets are essential for in vitro biofilm formation by Streptococcus mutans or Streptococcus gordonii grown in human plasma. The biofilms were composed of bacterial floes embedded with platelet aggregates in layers, and a similar architecture was also detected in situ on the injured valves of a rat model of experimental endocarditis. Similar to planktonic cells, the streptococci in biofilms were also able to induce platelet aggregation, which facilitates multilayer biofilm formation. Entrapping of platelets directly enhances the resistance of streptococcal biofilms to clindamycin. Prophylactic antibiotics or aspirin can reduce but not prevent or abolish biofilm formation on injured heart valves. Therefore, the platelet is a host factor for commensal streptococci in the circulation to consolidate biofilm formation and protect bacteria against antibiotics.

10 February 2015 in Circulation
Verified
Journal Article
Closed access
PDF file
CJChiau-Jing Jung
Chiau-Jing Jung
CYChiou-Yueh Yeh
Chiou-Yueh Yeh
RHRon-Bin Hsu
Ron-Bin Hsu
CLChii-Ming Lee
Chii-Ming Lee
CSChia-Tung Shun
Chia-Tung Shun
JCJean-San Chia
Jean-San Chia
Background—: Endocarditis-inducing streptococci form multilayered biofilms in complex with aggregated platelets on injured heart valves, but the host factors that interconnect and entrap these bacteria-platelet aggregates to promote vegetation formation were unclear. Methods and Results—: In a Streptococcus mutans endocarditis rat model, we identified layers of neutrophil extracellular traps interconnecting and entrapping bacteria-platelet aggregates inside vegetation that could be reduced significantly in size along with diminished colonizing bacteria by prophylaxis with intravascular DNase I alone. The combination of activated platelets and specific immunoglobulin G–adsorbed bacteria are required to induce the formation of neutrophil extracellular traps through multiple activation pathways. Bacteria play key roles in coordinating the signaling through spleen tyrosine kinase, Src family kinases, phosphatidylinositol-3-kinase, and p38 mitogen-activated protein kinase pathways to upregulate the expression of P-selectin in platelets, while inducing reactive oxygen species–dependent citrullination in the arm of neutrophils. Neutrophil extracellular traps in turn serve as the scaffold to further enhance and entrap bacteria-platelet aggregate formation and expansion. Conclusions—: Neutrophil extracellular traps promote and expand vegetation formation through enhancing and entrapping bacteria-platelet aggregates on the injured heart valves. (Circulation. 2015;131:571–581. DOI: 10.1161/CIRCULATIONAHA.114.011432.)

17 August 2012 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
ASA Sun
A Sun
YWYi-Ping Wang
Yi-Ping Wang
HLHp Lin
Hp Lin
JCJs Chia
Js Chia
CCCp Chiang
Cp Chiang

11 November 2009 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
CJChiau‐Jing Jung
Chiau‐Jing Jung
QZQuan‐Hau Zheng
Quan‐Hau Zheng
YSYa‐Hsiung Shieh
Ya‐Hsiung Shieh
CLChi‐Shuan Lin
Chi‐Shuan Lin
JCJean‐San Chia
Jean‐San Chia
Summary: Streptococcus mutans, a commensal of the human oral cavity, can survive in the bloodstream and cause infective endocarditis (IE). However, the virulence factors associated with this manifestation of disease are not known. Here, we demonstrate that AtlA, an autolysin of S. mutans is a newly identified fibronectin (Fn) binding protein and contributes to bacterial resistance to phagocytosis and survival in the bloodstream. Interestingly, prior exposure to plasma at low concentrations was sufficient to enhance bacterial survival in the circulation. Calcium ions at physiological plasma concentrations induced maturation of AtlA from the 104–90 kDa isoform resulting in increased Fn binding and resistance to phagocytosis. An isogenic mutant strain defective in AtlA expression exhibited reduced survival and virulence when tested in a rat model of IE compared with the wild‐type and complemented strains. The data presented suggest that plasma components utilized by S. mutans enhanced survival in the circulation and AtlA is a virulence factor associated with infective endocarditis.

19 January 2022 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
HKHsiang-Fong Kao
Hsiang-Fong Kao
BLBin-Chi Liao
Bin-Chi Liao
YHYen-Lin Huang
Yen-Lin Huang
HHHuai-Cheng Huang
Huai-Cheng Huang
CCChun-Nan Chen
Chun-Nan Chen
RHRuey-Long Hong
Ruey-Long Hong
Purpose: EGFR pathway inhibition may promote anti–programmed cell death protein 1 (PD-1) responses in preclinical models, but how EGFR inhibition affects tumor antigen presentation during anti–PD-1 monotherapy in humans remain unknown. We hypothesized that afatinib, an irreversible EGFR tyrosine kinase inhibitor, would improve outcomes in patients treated with pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) by promoting antigen presentation and immune activation in the tumor microenvironment. Patients and Methods: The ALPHA study (NCT03695510) was a single-arm, Phase II study with Simon's 2-stage design. Afatinib and pembrolizumab were administered to patients with platinum-refractory, recurrent, or metastatic HNSCC. The primary endpoint was the objective response rate (ORR). The study applied gene expression analysis using a NanoString PanCancer Immune Profiling Panel and next-generation sequencing using FoundationOne CDx. Results: From January 2019 to March 2020, the study enrolled 29 eligible patients. Common treatment-related adverse events were skin rash (75.9%), diarrhea (58.6%), and paronychia (44.8%). Twelve patients (41.4%) had an objective partial response to treatment. The median progression-free survival was 4.1 months, and the median overall survival was 8.9 months. In a paired tissue analysis, afatinib–pembrolizumab were found to upregulate genes involved in antigen presentation, immune activation, and natural killer cell–mediated cytotoxicity. Unaltered methylthioadenosine phosphorylase and EGFR amplification may predict the clinical response to the therapy. Conclusions: Afatinib may augment pembrolizumab therapy and improve the ORR in patients with HNSCC. Bioinformatics analysis suggested the enhancement of antigen presentation machinery in the tumor microenvironment.

1 January 2019 in Oral Oncology
Verified
Journal Article
Closed access
LWLing-Ying Wei
Ling-Ying Wei
JLJang-Jaer Lee
Jang-Jaer Lee
CYChiou-Yueh Yeh
Chiou-Yueh Yeh
CYChia-Ju Yang
Chia-Ju Yang
SKSang-Heng Kok
Sang-Heng Kok
JCJean-San Chia
Jean-San Chia